Anti Infectives: World Market, 2nd Edition, Vol II: Antibacterials

Kalorama Information
April 1, 2007
276 Pages - SKU: KLI1399449
License type:
Table of Contents Search inside this report Related Reports
Countries covered: Global

The market for antibiotics has changed and a knowledge of the current drug resistance situation is critical before operating in this marketplace. The effectiveness of many antibacterials (antibiotics) is being reduced as more and more types of bacteria become resistant to them.

These and other developments are covered in Kalorama's Anti-Infectives, World Markets, Vol. II: Antibacterials providing extensive detail on the anti-bacterial market, including the following critical trends:

  • Drug resistance and Interactions
  • Antibiotic Abuse
  • Antibiotic Cycling
  • Addressing Market Trends
  • Antibiotic Use in Agriculture
  • Antibiotic Education
  • Children and Bacterial Resistance
  • The Elderly and Bacterial Resistance
  • Compromised Individuals and Bacterial Resistance
  • Screening Hospital Patients
  • Side Effects of Antibiotics
  • Partnerships and Alliances
  • Environment and Drug Resistance
  • Methicillin Resistant Staphylococcus Aureus

The title is part of Kalorama Information's Anti-Infectives series, which represents a total decison and problem-solving support tool for decision makers in the pharmaceutical industry dealing with anti-infectives, or those assisting customers or looking at investments in this area.

Because of antibiotic resitance and other changing dynamics, knowledge of issues and trends is necessary to operate the antibacterials market. In this, the second volume of Kalorama Information's Anti-Infective Markets series, the antibacterial drug market is broken down into seven general categories based on drug class:

  • cephalosporins
  • macrolides
  • penicillins
  • quinolones
  • sulfonamides
  • tetracyclines
  • other misc. antibiotics
There is a significant trend shift occuring in the antibacterials market since Kalorama Information's last edition in 2005. Anti-Infectives Vol. II: Antibacterials covers that shift in detail. For each marketplace segment, Market Size, Growth and Share are provided, and revenue is forecasted to 2011 are provided. Current products are discussed and new pipeline products are assessed. This report also breaks out marketplace data by Infection Type the only publication to do so. In total, over 100 Tables and Figures provide accessible data on this growing market, a depth of coverage unsurpassed by any competitive study.

The following companies are profiled as part of this report:

  • Abbott Laboratories
  • AstraZeneca
  • Bayer Schering Pharma
  • Cubist Pharmaceuticals
  • Daiichi Sankyo
  • GlaxoSmithKline
  • Johnson & Johnson Group
  • King Pharmaceuticals
  • Merck & Company, Inc.
  • Pfizer, Inc.
  • Roche
  • Sanofi-Aventis
  • Wyeth


More Global Infectious Diseases Reports

2012 World Infectious Disease Testing Market Overview: Facilities, Test Volumes, and Sales Forecasts by Country by Venture Planning Group
This report provides a worldwide overview of the infectious disease testing market environment, structure, size and growth. Includes estimates of the number of laboratories ...

2012 Global Infectious Disease Testing Market Outlook: Growth Opportunities and Strategies by Venture Planning Group
The infectious disease testing market is one of the most rapidly growing segments of the in vitro diagnostics industry, and the greatest challenge facing suppliers ...

Global Infectious Disease Treatment Market 2011-2014 by Infiniti Research Limited
TechNavio’s analysts forecast the Global Infectious Disease Treatment market to grow at a CAGR of 8.1 percent over the period 2011–2014. One of the key ...

World Market for Anti-Infectives: Antifungals, Antibacterials and Antivirals (Treatments for HIV, HBV, HCV, Urinary Tract, Respiratory, Candidiasis and Other Infections) by Kalorama Information
This Kalorama Information report – The World Market for Anti-Infectives - focuses on three key segments of treatment: Antifungals (Allylamines, Azoles, ...

Future Infectious Disease Testing Market: Growth Opportunities, Business Strategies, Market Entry Barriers and Risks by Venture Planning Group
The report identifies the major opportunities for infectious disease testing instrumentation, reagent kits/test panels, consumables, as well as IT and auxiliary products; proposes design criteria ...

See all reports like this >>

 

Share this report


Other tasks

 
 

Research Assistance

Ask a question
 

Related Markets


Infectious Diseases Reports

 
 

Free Alert Me service

Receive bi-weekly email alerts on new market research

Sign Up Today!